Lei Liu1, Kathryn N Kearns1, Ilyas Eli2, Khadijeh A Sharifi1,3, Sauson Soldozy1, Elizabeth W Carlson2, Kyle W Scott1, M Filip Sluzewski4, Scott T Acton4, Kenneth A Stauderman5, M Yashar S Kalani1,3, Min Park1, Petr Tvrdik1,3. 1. Department of Neurological Surgery (L.L., K.N.K., K.A. Sharifi, S.S., K.W.S., M.Y.S.K., M.P., P.T.), University of Virginia Health System, Charlottesville. 2. Department of Neurosurgery (I.E., E.W.C.), University of Utah School of Medicine, Salt Lake City. 3. Department of Neuroscience (K.A. Sharifi, M.Y.S.K., P.T.), University of Virginia Health System, Charlottesville. 4. Department of Electrical and Computer Engineering (M.F.S., S.T.A.), University of Virginia Health System, Charlottesville. 5. CalciMedica (K.A. Stauderman), San Diego, CA.
Abstract
BACKGROUND AND PURPOSE: Ischemic injury triggers multiple pathological responses in the brain tissue, including spreading depolarizations across the cerebral cortex (cortical spreading depolarizations [CSD]). Microglia have been recently shown to play a significant role in the propagation of CSD. However, the intracellular responses of myeloid cells during ischemic stroke have not been investigated. METHODS: We have studied intracellular calcium activity in cortical microglia in the stroke model of the middle cerebral artery occlusion, using the murine Polr2a-based and Cre-dependent GCaMP5 and tdTomato reporter (PC::G5-tdT). High-speed 2-photon microscopy through cranial windows was employed to record signals from genetically encoded indicators of calcium. Inflammatory stimuli and pharmacological inhibition were used to modulate microglial calcium responses in the somatosensory cortex. RESULTS: In vivo imaging revealed periodical calcium activity in microglia during the hyperacute phase of ischemic stroke. This activity was more frequent during the first 6 hours after occlusion, but the amplitudes of calcium transients became larger at later time points. Consistent with CSD nature of these events, we reproducibly triggered comparable calcium transients with microinjections of potassium chloride (KCl) into adjacent cortical areas. Furthermore, lipopolysaccharide-induced peripheral inflammation, mimicking sterile inflammation during ischemic stroke, produced significantly greater microglial calcium transients during CSD. Finally, in vivo pharmacological analysis with CRAC (calcium release-activated channel) inhibitor CM-EX-137 demonstrated that CSD-associated microglial calcium transients after KCl microinjections are mediated at least in part by the CRAC mechanism. CONCLUSIONS: Our findings demonstrate that microglia participate in ischemic brain injury via previously undetected mechanisms, which may provide new avenues for therapeutic interventions.
BACKGROUND AND PURPOSE: Ischemic injury triggers multiple pathological responses in the brain tissue, including spreading depolarizations across the cerebral cortex (cortical spreading depolarizations [CSD]). Microglia have been recently shown to play a significant role in the propagation of CSD. However, the intracellular responses of myeloid cells during ischemic stroke have not been investigated. METHODS: We have studied intracellular calcium activity in cortical microglia in the stroke model of the middle cerebral artery occlusion, using the murine Polr2a-based and Cre-dependent GCaMP5 and tdTomato reporter (PC::G5-tdT). High-speed 2-photon microscopy through cranial windows was employed to record signals from genetically encoded indicators of calcium. Inflammatory stimuli and pharmacological inhibition were used to modulate microglial calcium responses in the somatosensory cortex. RESULTS: In vivo imaging revealed periodical calcium activity in microglia during the hyperacute phase of ischemic stroke. This activity was more frequent during the first 6 hours after occlusion, but the amplitudes of calcium transients became larger at later time points. Consistent with CSD nature of these events, we reproducibly triggered comparable calcium transients with microinjections of potassium chloride (KCl) into adjacent cortical areas. Furthermore, lipopolysaccharide-induced peripheral inflammation, mimicking sterile inflammation during ischemic stroke, produced significantly greater microglial calcium transients during CSD. Finally, in vivo pharmacological analysis with CRAC (calcium release-activated channel) inhibitor CM-EX-137 demonstrated that CSD-associated microglial calcium transients after KCl microinjections are mediated at least in part by the CRAC mechanism. CONCLUSIONS: Our findings demonstrate that microglia participate in ischemic brain injury via previously undetected mechanisms, which may provide new avenues for therapeutic interventions.
Authors: Martin Lauritzen; Jens Peter Dreier; Martin Fabricius; Jed A Hartings; Rudolf Graf; Anthony John Strong Journal: J Cereb Blood Flow Metab Date: 2010-11-03 Impact factor: 6.200
Authors: Christian Dohmen; Oliver W Sakowitz; Martin Fabricius; Bert Bosche; Thomas Reithmeier; Ralf-Ingo Ernestus; Gerrit Brinker; Jens P Dreier; Johannes Woitzik; Anthony J Strong; Rudolf Graf Journal: Ann Neurol Date: 2008-06 Impact factor: 10.422
Authors: Nina Eriksen; Egill Rostrup; Martin Fabricius; Michael Scheel; Sebastian Major; Maren K L Winkler; Georg Bohner; Edgar Santos; Oliver W Sakowitz; Vasilis Kola; Clemens Reiffurth; Jed A Hartings; Peter Vajkoczy; Johannes Woitzik; Peter Martus; Martin Lauritzen; Bente Pakkenberg; Jens P Dreier Journal: Neurology Date: 2018-12-28 Impact factor: 9.910
Authors: Rocío Fernández-Serra; Emma Martínez-Alonso; Alberto Alcázar; Mourad Chioua; José Marco-Contelles; Ricardo Martínez-Murillo; Milagros Ramos; Gustavo V Guinea; Daniel González-Nieto Journal: Int J Mol Sci Date: 2022-07-04 Impact factor: 6.208
Authors: Kathryn N Kearns; Lei Liu; Sauson Soldozy; Khadijeh A Sharifi; Mark E Shaffrey; Min S Park; Petr Tvrdik Journal: Neurocrit Care Date: 2022-03-15 Impact factor: 3.532